For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250728:nRSb7699Sa&default-theme=true
RNS Number : 7699S Gelion PLC 28 July 2025
Gelion plc
("Gelion" or the "Company")
Block Admission Return
The Company provides the following update in accordance with Schedule Six of
the AIM Rules for Companies regarding its existing block admission
arrangements:
a Name of company Gelion plc
b Name of scheme Gelion plc scheme:
Shares
Existing Share Option Plan
8,100,000
c Period of return (from/to) 26 January 2025 to 26 July 2025
d Number and Class of Securities not issued at the start of the period under the 7,901,856 ordinary shares of 0.1p each
scheme
e Additional listing Nil
f Number of securities issued under the scheme during the period
Shares
Existing Share Option Plan
28,916
g Balance under the scheme of securities not yet issued at the end of the period
Shares
Existing Share Option Plan
7,872,940
h Number and class of securities originally admitted and the date of admission 8,100,000 ordinary shares of 0.1p each on 26 January 2022
i Contact name - Company Amit Gupta
Telephone number +44 (0) 20 3405 0205
Contact name - Strand Hanson Limited Christopher Raggett
Telephone number +44 (0) 20 7409 3494
CONTACTS
Gelion plc via Alma
John Wood, CEO
Amit Gupta, CFO
Strand Hanson Limited (Nominated and Financial Adviser) +44 (0) 20 7409 3494
Christopher Raggett / Rob Patrick
Oberon Capital (Joint Broker) +44 (0) 20 3179 5300
Nick Lovering / Adam Pollock
Allenby Capital Limited (Joint Broker)
Jos Pinnington / Guy McDougall (Sales and Corporate Broking) +44 (0) 20 3328 5656
Alex Brearley / Ashur Joseph (Corporate Finance)
Alma Strategic Communications (Financial PR) +44 (0) 20 3405 0205
Justine James / Hannah Campbell / Rose Docherty gelion@almastrategic.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END BLRPKFBQPBKKNOB